Overview
Squamous cell carcinoma of the oropharynx (also called oropharyngeal squamous cell carcinoma, or OPSCC) is a type of cancer that starts in the oropharynx — the middle part of the throat. This includes the base of the tongue, the soft palate (the back part of the roof of the mouth), the tonsils, and the back wall of the throat. The cancer grows from flat, thin cells called squamous cells that line these surfaces. This cancer can cause a range of symptoms depending on where exactly it starts. Common signs include a persistent sore throat, difficulty swallowing, a lump in the neck, ear pain, and changes in the voice. Many people first notice a painless lump in the neck, which happens when cancer spreads to nearby lymph nodes. Because these symptoms can seem like everyday problems, the cancer is sometimes found at a later stage. There are two main causes of this cancer. One is long-term use of tobacco and alcohol. The other — and now the most common cause in many countries — is infection with human papillomavirus (HPV), especially HPV type 16. HPV-related oropharyngeal cancer tends to affect younger, non-smoking adults and generally responds better to treatment. Treatment usually involves surgery, radiation therapy, chemotherapy, or a combination of these. Newer targeted therapies and immunotherapy drugs are also being used. With modern treatment, many people — especially those with HPV-related disease — have good outcomes.
Key symptoms:
Persistent sore throat that does not go awayDifficulty or pain when swallowingA lump or swelling in the neckEar pain, especially on one sideChanges in voice or hoarsenessUnexplained weight lossA sore or ulcer in the back of the mouth or throat that does not healFeeling like something is stuck in the throatCoughing up bloodJaw pain or stiffnessBad breath that does not improveNumbness in the mouth or throat area
Multifactorial
Caused by a mix of several genes and environmental factors
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsSara Medek — PHASE2
NYU Langone Health — PHASE1, PHASE2
UNICANCER — NA
Indiana University — NA
Ryan Carey — PHASE1
Royal North Shore Hospital — NA
NexImmune Inc. — PHASE1
University of Vermont Medical Center — PHASE2
BlueSky Immunotherapies GmbH — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Squamous cell carcinoma of the oropharynx.
20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Squamous cell carcinoma of the oropharynx.
Community
No community posts yet. Be the first to share your experience with Squamous cell carcinoma of the oropharynx.
Start the conversation →Latest news about Squamous cell carcinoma of the oropharynx
Disease timeline:
New recruiting trial: ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: Training Swallowing Initiation During Expiration
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
New recruiting trial: De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Is my cancer HPV-positive or HPV-negative, and how does that affect my treatment and prognosis?,What stage is my cancer, and what does that mean for my treatment options?,What are the likely side effects of treatment, and how can we manage them?,Is there a clinical trial I might be eligible for, especially one looking at reducing treatment intensity?,Will I need a feeding tube during treatment, and how long might I need it?,What follow-up schedule do you recommend after treatment to check for recurrence?,Should my family members be concerned about their own cancer risk, and should they be screened?
Common questions about Squamous cell carcinoma of the oropharynx
What is Squamous cell carcinoma of the oropharynx?
Squamous cell carcinoma of the oropharynx (also called oropharyngeal squamous cell carcinoma, or OPSCC) is a type of cancer that starts in the oropharynx — the middle part of the throat. This includes the base of the tongue, the soft palate (the back part of the roof of the mouth), the tonsils, and the back wall of the throat. The cancer grows from flat, thin cells called squamous cells that line these surfaces. This cancer can cause a range of symptoms depending on where exactly it starts. Common signs include a persistent sore throat, difficulty swallowing, a lump in the neck, ear pain, and
How is Squamous cell carcinoma of the oropharynx inherited?
Squamous cell carcinoma of the oropharynx follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Squamous cell carcinoma of the oropharynx typically begin?
Typical onset of Squamous cell carcinoma of the oropharynx is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Squamous cell carcinoma of the oropharynx?
Yes — 20 recruiting clinical trials are currently listed for Squamous cell carcinoma of the oropharynx on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Squamous cell carcinoma of the oropharynx?
25 specialists and care centers treating Squamous cell carcinoma of the oropharynx are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.